About Atisa Lifesciences
Atisa Lifesciences is a company based in Hyderabad (India) founded in 2018. It operates as a B2B and Manufacturing and Distribution. Atisa Lifesciences offers products and services including Futran, Tidar, Peglip, Zyterone, and Lenodo.
- Headquarter Hyderabad, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Atisa Life Sciences Private Limited
- Date of Incorporation 21 Dec, 2010
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$63.58 K (USD)-4.47as on Mar 31, 2022
-
Net Profit
-$64.63 K (USD)15.03as on Mar 31, 2022
-
EBITDA
-$37.76 K (USD)38.33as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Atisa Lifesciences
Atisa Lifesciences offers a comprehensive portfolio of products and services, including Futran, Tidar, Peglip, Zyterone, and Lenodo.
Fulvestrant injection for treating breast cancer patients
Temozolomide injection used in brain tumor therapy
Pegylated liposomal doxorubicin for cancer treatment
Abiraterone acetate tablets for prostate cancer care
Lenalidomide capsules for multiple myeloma management
Funding Insights of Atisa Lifesciences
Detailed funding history for Atisa Lifesciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Atisa Lifesciences
Investment portfolio details for Atisa Lifesciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Atisa Lifesciences
Detailed financials for Atisa Lifesciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Atisa Lifesciences Comparisons
Peer comparison for Atisa Lifesciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Atisa Lifesciences
Detailed competitors of Atisa Lifesciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Atisa Lifesciences
Complete news archive for Atisa Lifesciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atisa Lifesciences
Atisa Lifesciences was founded in 2018.
Atisa Lifesciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Annual revenue of Atisa Lifesciences is $63.58K as on Mar 31, 2022.
Atisa Lifesciences is a specialty pharmaceutical company based in India, emphasizing high-quality medicine production adhering to GMP guidelines. It focuses on therapeutic areas like oncology, nephrology, and hepatology, developing innovative drugs through research and collaboration. The company aims to improve patient survival and quality of life by providing affordable treatments globally, with manufacturing processes ensuring regulatory compliance and stringent standards.
Atisa Lifesciences offers Futran, Tidar, Peglip, Zyterone, and Lenodo.